Citric Acid - British Pharmacopoeia
Citric Acid - British Pharmacopoeia
Previous Next Hide Timeline Show Change Symbols Show Change Details
Status: You are viewing the legally effective version.
Citric Acid1
General Notices
Ph Eur
DEFINITION
2-Hydroxypropane-1,2,3-tricarboxylic acid.
Content
♦ CHARACTERS
Appearance
Solubility
mp
IDENTIFICATION
Second identification: A, C, D, E.
♢ C. Add about 5 mg to a mixture of 1 mL of acetic anhydride R and 3 mL of pyridine R. A red colour develops.
D. Dissolve 0.5 g in 5 mL of water R, neutralise using 1 M sodium hydroxide (about 7 mL), add 10 mL of calcium chloride solution R and heat to boiling. A
white precipitate is formed.
E. Water (see Tests).♢
TESTS
Appearance of solution
https://www.pharmacopoeia.com/bp-2020/monographs/citric-acid1.html?date=2020-07-01&text=Citric+acid+anhydrous+ 1/3
8/23/2020 Citric Acid - British Pharmacopoeia
The solution is clear (2.2.1) and colourless or not more intensely coloured than reference solution Y7, BY7 or GY7 (2.2.2, Method II).
To 1.0 g in a cleaned test tube add 10 mL of sulfuric acid R and immediately heat the mixture in a water-bath at 90 ± 1 °C for 60 min. Cool rapidly
immediately afterwards. The solution is not more intensely coloured than a mixture of 1 mL of red primary solution and 9 mL of yellow primary solution
(2.2.2, Method I).
Oxalic acid
Dissolve 0.80 g in 4 mL of water R. Add 3 mL of hydrochloric acid R and 1 g of zinc R in granules. Boil for 1 min. Allow to stand for 2 min. Transfer the
supernatant to a test-tube containing 0.25 mL of a 10 g/L solution of phenylhydrazine hydrochloride R and heat to boiling. Cool rapidly, transfer to a
graduated cylinder and add an equal volume of hydrochloric acid R and 0.25 mL of a 50 g/L solution of potassium ferricyanide R. Shake and allow to stand
for 30 min. Any pink colour in the solution is not more intense than that in a standard prepared at the same time in the same manner using 4 mL of a
0.1 g/L solution of oxalic acid R.
Sulfates (2.4.13)
Dissolve 2.0 g in distilled water R and dilute to 30 mL with the same solvent.
Aluminium (2.4.17)
Maximum 0.2 ppm, if intended for use in the manufacture of dialysis solutions.
Prescribed solution Dissolve 20 g in 100 mL of water R and add 10 mL of acetate buffer solution pH 6.0 R.
Reference solution Mix 2 mL of aluminium standard solution (2 ppm Al) R, 10 mL of acetate buffer solution pH 6.0 R and 98 mL of water R.
Blank solution Mix 10 mL of acetate buffer solution pH 6.0 R and 100 mL of water R.
Water (2.5.12)
Less than 0.5 IU/mg, if intended for use in the manufacture of parenteral preparations without a further appropriate procedure for the removal of bacterial
endotoxins.♦
ASSAY
Dissolve 0.550 g in 50 mL of water R. Titrate with 1 M sodium hydroxide, using 0.5 mL of phenolphthalein solution R as indicator.
♦ LABELLING
The label states, where applicable, that the substance is intended for use in the manufacture of dialysis solutions.♦
Ph Eur
1 This monograph has undergone pharmacopoeial harmonisation. See chapter 5.8 Pharmacopoeial harmonisation.
Previous Next
https://www.pharmacopoeia.com/bp-2020/monographs/citric-acid1.html?date=2020-07-01&text=Citric+acid+anhydrous+ 2/3
8/23/2020 Citric Acid - British Pharmacopoeia
https://www.pharmacopoeia.com/bp-2020/monographs/citric-acid1.html?date=2020-07-01&text=Citric+acid+anhydrous+ 3/3